Decision Resources, Inc., today announced its updated forecasts for CNS markets covered in its proprietary decision support tool, COMPETITIVE LANDSCAPE ™ for CNS. Featuring robust and continually updated data and analyses, COMPETITIVE LANDSCAPE is a unique, Web-based multiclient service that provides objective analysis of the critical factors that drive a drug's clinical strength and commercial potential.

(Photo: )

The new forecasts project drug sales in 10 key drug areas in CNS to the year 2007 and account for recent events in this dynamic market.

"The year 2001 saw critical events in the CNS market, not the least of which was the expiration of Prozac's patent in the United States," says Kate Hohenberg, Director of CNS Products at Decision Resources. "The pipeline for CNS products also looks dramatically different, with the dream of an Alzheimer's vaccine now deferred."

The Competitive Landscape tool allows market watchers to assess the impact of these events in a dynamic, easy-to-use Web-based interface. In addition to highlighting and analyzing the competitive aspects of both CNS development candidates and key marketed drugs, COMPETITIVE LANDSCAPE provides valuable insight on potential licensing opportunities and pharmaceutical company CNS franchise strength.

Analyses, based on extensive secondary sources, are further shaped by expert insight from Decision Resources' international CNS advisory board and complemented by in-depth interviews with more than 200 thought-leading physicians from around the globe. Outputs of COMPETITIVE LANDSCAPE for CNS compounds include developer company, current development status, mechanism of action, U.S. patent expiry, estimated launch year, clinical and commercial evaluations, forecasted sales, licensing status, and potential licensing opportunities. Assumptions and rationales for all analyses are fully documented. Users can use the product to evaluate products and their marketing companies' franchise strength.

For more information about how COMPETITIVE LANDSCAPE can help you, please contact: Joe Walsh, Vice President and Managing Director, North American Sales and Marketing, 781.296.2570, or

About Decision Resources

Decision Resources has provided strategic information services to the pharmaceutical and biotechnology industries for 30 years. The company continues to develop Web-based initiatives in several therapeutic areas to provide its clients immediate access to the most up-to-date information on the ever-changing dynamics of the biopharmaceutical industry. For more information, please visit our Web site at



AP Archive:

PRN Photo Desk, 888-776-6555 or 212-782-2840

SOURCE: Decision Resources, Inc.

Contact: Joe Walsh of Decision Resources, +1-781-296-2570, or

New Obesity Drugs on Horizon

View Now